E

Engimmune Therapeutics

21 employees

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biotechnology
T cell therapy
Immunotherapy
Therapeutics
machine learning
immunology
oncology

Date founded

2021

Funding rounds raised

Total raised

$16M

from 4 investors over 4 rounds

E

Engimmune Therapeutics raised $16M on May 3, 2022

Investors: Novo Holdings, Pureos Bioventures and Kinled Holding Ltd

E

Engimmune Therapeutics raised $546K on February 21, 2022

Investors: BaseLaunch

FAQ